HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS

<p>Background. A persistent infection with high-risk genotypes of human papilloma viruses (HPV) represents the most important etiologic factor for the development of cervical cancer, the second most frequent cancer in women in Slovenia as well as elsewhere in the world. In the detection of pre...

Full description

Bibliographic Details
Main Authors: Eda Vrtačnik Bokal, Andrej Možina, Mario Poljak
Format: Article
Language:English
Published: Slovenian Medical Association 2003-12-01
Series:Zdravniški Vestnik
Subjects:
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/2193
id doaj-85699467398949f8b0140edbf8482b99
record_format Article
spelling doaj-85699467398949f8b0140edbf8482b992020-11-24T20:59:14ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242003-12-017201678HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLSEda Vrtačnik Bokal0Andrej Možina1Mario Poljak2Ginekološka klinika Klinični center Šlajmerjeva 3 1525 LjubljanaGinekološka klinika Klinični center Šlajmerjeva 3 1525 LjubljanaInštitut za mikrobiologijo in imunologijo Medicinska fakulteta Korytkova 2 1000 Ljubljana<p>Background. A persistent infection with high-risk genotypes of human papilloma viruses (HPV) represents the most important etiologic factor for the development of cervical cancer, the second most frequent cancer in women in Slovenia as well as elsewhere in the world. In the detection of precancerous lesions the cervical Papanicolaou (Pap) smear screening is used in Slovenia and worldwide. Management of patients with repeat abnormal smears (Pap II) represents a great and complex clinical and public health problem; repeat cytologic examinations are the routine procedure in many countries, also in Slovenia, although the sensitivity of Pap smear testing in the detection of cervical intraepithelial neoplasms (CIN) II and III is relatively low. In cases of abnormal squamous cells and mildly dyskaryotic cells the presence of infections with high-risk HPV genotypes is being increasingly used as a complementary method to Pap smear testing.</p><p><br />Methods and patients. In the study we enrolled 148 women who within two years had three subsequent Pap II smears (abnormal squamous cells or mildly dyskaryotic cells). The prevalence of HPV infections was determined using three molecular tests: Hybrid Capture II (HCII) (Digene Corporation, Gaithersburg, USA) and two variants of polymerase chain reaction (PCR-PGMY11/PGMY09 and PCR-CPI/CPIIG). HPV genotypes were determined using the method of enzyme restriction of PCR products multiplied by group-specific oligonucleotid primers PGMY11/PGMY09.</p><p><br />Results. HPV infection was detected in 25.7% of women. In women aged ≤ 30 years a statistically significantly higher incidence of HPV infections was found (37.8%) than in women aged ≥ 30 years (20.4%). In women aged ≤ 30 years most frequent infections, and also equally distributed, were the ones with high-risk genotypes HPV 16 and HPV 73 and with a potentially high-risk genotype HPV 26. In women aged ≥ 30 years most frequent infections, and also equally distributed, were the ones with high-risk genotypes HPV 16 and with a potentially high-risk genotype HPV 53. The results of the three chosen molecular methods for the detection of HPV infections matched in 93.2%.</p><p>Conclusions. Our findings show that repeat Pap smears as the method of follow-up and detection of precancerous lesions do not provide relevant results due to low prevalence of HPV infections in Slovenia, which indirectly indicates low sensitivity and specificity of Pap smear testing. In the detection of HPV infections, molecular methods are thus sensitive screening tests to be used complementary to cytologic tests in women with abnormal squamous cells or mildly dyskaryotic cells.</p>http://vestnik.szd.si/index.php/ZdravVest/article/view/2193human papilloma virusabnormal squamous cellsmildly dyskaryotic cellsPapanicolau testcervical cancer
collection DOAJ
language English
format Article
sources DOAJ
author Eda Vrtačnik Bokal
Andrej Možina
Mario Poljak
spellingShingle Eda Vrtačnik Bokal
Andrej Možina
Mario Poljak
HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS
Zdravniški Vestnik
human papilloma virus
abnormal squamous cells
mildly dyskaryotic cells
Papanicolau test
cervical cancer
author_facet Eda Vrtačnik Bokal
Andrej Možina
Mario Poljak
author_sort Eda Vrtačnik Bokal
title HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS
title_short HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS
title_full HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS
title_fullStr HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS
title_full_unstemmed HUMAN PAPILLOMA VIRUS IN THE ABNORMAL SQUAMOUS CELLS AND MILDY DYSKARYOTIC CELLS
title_sort human papilloma virus in the abnormal squamous cells and mildy dyskaryotic cells
publisher Slovenian Medical Association
series Zdravniški Vestnik
issn 1318-0347
1581-0224
publishDate 2003-12-01
description <p>Background. A persistent infection with high-risk genotypes of human papilloma viruses (HPV) represents the most important etiologic factor for the development of cervical cancer, the second most frequent cancer in women in Slovenia as well as elsewhere in the world. In the detection of precancerous lesions the cervical Papanicolaou (Pap) smear screening is used in Slovenia and worldwide. Management of patients with repeat abnormal smears (Pap II) represents a great and complex clinical and public health problem; repeat cytologic examinations are the routine procedure in many countries, also in Slovenia, although the sensitivity of Pap smear testing in the detection of cervical intraepithelial neoplasms (CIN) II and III is relatively low. In cases of abnormal squamous cells and mildly dyskaryotic cells the presence of infections with high-risk HPV genotypes is being increasingly used as a complementary method to Pap smear testing.</p><p><br />Methods and patients. In the study we enrolled 148 women who within two years had three subsequent Pap II smears (abnormal squamous cells or mildly dyskaryotic cells). The prevalence of HPV infections was determined using three molecular tests: Hybrid Capture II (HCII) (Digene Corporation, Gaithersburg, USA) and two variants of polymerase chain reaction (PCR-PGMY11/PGMY09 and PCR-CPI/CPIIG). HPV genotypes were determined using the method of enzyme restriction of PCR products multiplied by group-specific oligonucleotid primers PGMY11/PGMY09.</p><p><br />Results. HPV infection was detected in 25.7% of women. In women aged ≤ 30 years a statistically significantly higher incidence of HPV infections was found (37.8%) than in women aged ≥ 30 years (20.4%). In women aged ≤ 30 years most frequent infections, and also equally distributed, were the ones with high-risk genotypes HPV 16 and HPV 73 and with a potentially high-risk genotype HPV 26. In women aged ≥ 30 years most frequent infections, and also equally distributed, were the ones with high-risk genotypes HPV 16 and with a potentially high-risk genotype HPV 53. The results of the three chosen molecular methods for the detection of HPV infections matched in 93.2%.</p><p>Conclusions. Our findings show that repeat Pap smears as the method of follow-up and detection of precancerous lesions do not provide relevant results due to low prevalence of HPV infections in Slovenia, which indirectly indicates low sensitivity and specificity of Pap smear testing. In the detection of HPV infections, molecular methods are thus sensitive screening tests to be used complementary to cytologic tests in women with abnormal squamous cells or mildly dyskaryotic cells.</p>
topic human papilloma virus
abnormal squamous cells
mildly dyskaryotic cells
Papanicolau test
cervical cancer
url http://vestnik.szd.si/index.php/ZdravVest/article/view/2193
work_keys_str_mv AT edavrtacnikbokal humanpapillomavirusintheabnormalsquamouscellsandmildydyskaryoticcells
AT andrejmozina humanpapillomavirusintheabnormalsquamouscellsandmildydyskaryoticcells
AT mariopoljak humanpapillomavirusintheabnormalsquamouscellsandmildydyskaryoticcells
_version_ 1716783217778884608